Literature DB >> 6336918

Parenteral and oral antibiotics in elective colon and rectal surgery. A prospective, randomized trial.

G F Coppa, K Eng, T H Gouge, J H Ranson, S A Localio.   

Abstract

Our evaluation consisted of a prospective, randomized clinical trial in a homogenous group of 241 patients undergoing elective colon and rectal resections. A significant decrease in wound infection was found in the patients who received intravenous cefoxitin in conjunction with standard bowel preparation. The infection rate correlated with the type of resection; rectal resections had the highest rate in each study group, but parenteral prophylaxis produced a significantly lower wound infection rate. E. coli and Staph. aureus were the most common bacterial isolates in both groups. B. fragilis was recovered in only two Group A patients, which most likely reflects the exceedingly low recovery rate of anaerobic bacteria in our laboratory. Urinary cultures were positive in a large number of patients and reflect the standard use of Foley catheterization in all patients who undergo resection of the colon or rectum. These data indicate that perioperative prophylactic administration of cefoxitin reduces the wound sepsis rate when combined with oral antibiotics and mechanical bowel preparation in patients undergoing resection of the colon or rectum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336918     DOI: 10.1016/0002-9610(83)90167-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  18 in total

1.  Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients.

Authors:  R Tang; H H Chen; Y L Wang; C R Changchien; J S Chen; K C Hsu; J M Chiang; J Y Wang
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

2.  Right colon, left colon, and rectal surgeries are not similar for surgical site infection development. Analysis of 277 elective and urgent colorectal resections.

Authors:  Luca Degrate; Mattia Garancini; Marta Misani; Silvia Poli; Cinzia Nobili; Fabrizio Romano; Laura Giordano; Vittorio Motta; Franco Uggeri
Journal:  Int J Colorectal Dis       Date:  2010-10-05       Impact factor: 2.571

3.  Implementing a standard protocol to decrease the incidence of surgical site infections in rectal cancer surgery.

Authors:  Minako Kobayashi; Yasuhiro Inoue; Yasuhiko Mohri; Chikao Miki; Masato Kusunoki
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

4.  Elective colon and rectal surgery differ in risk factors for wound infection: results of prospective surveillance.

Authors:  Tsuyoshi Konishi; Toshiaki Watanabe; Junji Kishimoto; Hirokazu Nagawa
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 5.  The role of oral antibiotics prophylaxis in prevention of surgical site infection in colorectal surgery.

Authors:  Michalis Koullouros; Nadir Khan; Emad H Aly
Journal:  Int J Colorectal Dis       Date:  2016-10-24       Impact factor: 2.571

Review 6.  Bowel Preparation before Elective Surgery.

Authors:  Anjali S Kumar; Deirdre C Kelleher; Gavin W Sigle
Journal:  Clin Colon Rectal Surg       Date:  2013-09

Review 7.  Infection control in colon surgery.

Authors:  Donald E Fry
Journal:  Langenbecks Arch Surg       Date:  2016-06-27       Impact factor: 3.445

Review 8.  Benefit of mechanical bowel preparation prior to elective colorectal surgery: current insights.

Authors:  A C A Murray; R P Kiran
Journal:  Langenbecks Arch Surg       Date:  2016-06-20       Impact factor: 3.445

9.  A statewide assessment of surgical site infection following colectomy: the role of oral antibiotics.

Authors:  Michael J Englesbe; Linda Brooks; James Kubus; Martin Luchtefeld; James Lynch; Anthony Senagore; John C Eggenberger; Vic Velanovich; Darrell A Campbell
Journal:  Ann Surg       Date:  2010-09       Impact factor: 12.969

10.  Wound infection after elective colorectal resection.

Authors:  Robert L Smith; Jamie K Bohl; Shannon T McElearney; Charles M Friel; Margaret M Barclay; Robert G Sawyer; Eugene F Foley
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.